LinkedIn Tracking Pixel

Aligning Local with Global for GSK in EMERGING MARKETS

GSK is a multinational pharma company. As they drive growth in emerging markets across the globe, capability building has become a key cornerstone of their talent practices. In line with business objectives, GSK wanted to ensure a strong internal talent pipeline and development of their Front Line and Second Line Sales Leaders.

Success_Stories_Visual1

Jombay is deploying a Hybrid Assessment Center for these GSK sales leaders in Turkey, Argentina, Thailand and a few other countries. Here are some ways in which we are ensuring alignment with global organizational talent practices at GSK:

  • Org Specific Competencies. We designed the assessment center experience mapped to GSK’s global org competencie
  • Parity in Assessment Tool Experience. We deployed a mix of tools which were uniform globally (with local language adaptations wherever necessary) . These included a Simulation, Case Study, Behavioral Event Interview, and a Scientific Landscape Interview.
  • Benchmarked Insights. Jombay will deliver Individual reports and a National level emerging market report to aid in charting next steps useful to the capability building program.

Do reach out if you too would like to run an Assessment & Development center relevant to your context!

Assessment Centers
Managerial Development
Pharma
Succession Planning
Recent Posts
Why CCIL doesn't leave succession readiness to chance
Why CCIL doesn't leave succession readiness to chance
At CCIL, one of India’s key financial market institutions, senior...
Jun 23, 2026
Jombay > helping Comviva's best technical minds become its next leaders
Jombay > helping Comviva's best technical minds become its next leaders
Comviva operates across 90+ countries, serving over 200 communication service...
Jun 08, 2026
Jombay > helps Glenmark build their pipeline across levels
Jombay > helps Glenmark build their pipeline across levels
Glenmark Pharmaceuticals, a global pharmaceutical company, partnered with
May 25, 2026